Lipid A controls the robustness of intratumoral accumulation of attenuated Salmonella in mice

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Cancer

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.28700PMID 24374783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

  2012cited by this paper
• In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis

  2011cited by this paper
• A Systems Approach for Tumor Pharmacokinetics

  2011cited by this paper
• Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium.

  2011influential reference
• Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer.

  2010cited by this paper
• Engineering the perfect (bacterial) cancer therapy

  2010cited by this paper
• Salmonella—allies in the fight against cancer

  2010cited by this paper
• Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice

  2009cited by this paper
• Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis.

  2009cited by this paper
• Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α

  2009influential reference
• Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors

  2009cited by this paper
• Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand

  2008cited by this paper
• Integrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategies.

  2008cited by this paper
• Plasmid-borne prokaryotic gene expression: sources of variability and quantitative system characterization.

  2008cited by this paper
• Hypoxia in cancer: significance and impact on clinical outcome

  2007cited by this paper
• Drug resistance and the solid tumor microenvironment.

  2007cited by this paper
• Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth

  2007cited by this paper
• Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis.

  2007cited by this paper
• Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro

  2006cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• Acute Inflammatory Response to Endotoxin in Mice and Humans

  2005cited by this paper
• Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium.

  2005cited by this paper
• Systemic Administration of an Attenuated, Tumor-Targeting Salmonella typhimurium to Dogs with Spontaneous Neoplasia: Phase I Evaluation

  2005cited by this paper
• Molecular mechanisms involved in the pathogenesis of septic shock.

  2004cited by this paper
• Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack.

  2004cited by this paper
• Bacteria as tumour-targeting vectors.

  2003cited by this paper
• Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

  2003cited by this paper
• Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock

  2003cited by this paper
• Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors.

  2003cited by this paper
• Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma.

  2003cited by this paper
• Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

  2002influential reference
• Tumor-Targeted Salmonella

  2002cited by this paper
• Differential clearance and induction of host responses by various administered or released lipopolysaccharides

  2001cited by this paper
• Comparative Evaluation of the Acute Toxic Effects in Monkeys, Pigs and Mice of a Genetically Engineered Salmonella Strain (VNP20009) Being Developed as an Antitumor Agent

  2000cited by this paper
• Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

  2000cited by this paper
• Tumor-targeted Salmonella. Highly selective delivery vectors.

  2000influential reference
• Escherichia coli msbB Gene as a Virulence Factor and a Therapeutic Target

  1999cited by this paper
• Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo

  1999cited by this paper
• A lethal role for lipid A in Salmonella infections

  1998cited by this paper
• Tumor-targeted Salmonella as a novel anticancer vector.

  1997cited by this paper
• Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans.

  1995cited by this paper
• Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.

  1992cited by this paper

• Quorum Sensing: Not Just a Bridge Between Bacteria

  2025cites this paper
• A Review of Engineered Bacterial Nanobots for Targeted Cancer Therapy

  2025cites this paper
• Controlling intracellular protein delivery, tumor colonization and tissue distribution using the master regulator flhDC in a clinically relevant ΔsseJ Salmonella strain.

  2024cites this paper
• Emerging Applications of Bacteria as Antitumor Agents.

  2021cites this paper
• Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches

  2021cites this paper
• Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy

  2020cites this paper
• Detection of tumors with fluoromarker‐releasing bacteria

  2019cites this paper
• Bacterial Targeting of Tumors

  2019cites this paper
• Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy.

  2019cites this paper
• Endostatin gene therapy delivered by attenuated Salmonellatyphimurium in murine tumor models

  2018cites this paper
• White paper on microbial anti-cancer therapy and prevention

  2018cites this paper
• Synthetic biology strategies towards the development of new bioinspired technologies for medical applications

  2017cites this paper
• Advances in bacterial cancer therapies using synthetic biology.

  2017cites this paper
• The inhibition of indoleamine 2, 3-dioxygenase 1 by connexin 43

  2017cites this paper
• Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities.

  2016cites this paper
• Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses

  2016cites this paper
• Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors

  2015cites this paper
• Trg-deficient Salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating.

  2015cites this paper
• Potent and tumor specific: arming bacteria with therapeutic proteins.

  2015cites this paper
• Genetically modified bacteria as a tool to detect microscopic solid tumor masses with triggered release of a recombinant biomarker.

  2015cites this paper
• Quorum-sensing Salmonella selectively trigger protein expression within tumors

  2015cites this paper
• Engineering Novel Detection and Treatment Strategies for Bacterial Therapy of Cancer

  2015cites this paper
• Bacterial Cancer Therapy: How Patients Might Benefit from Salmonella Infections

  2015cites this paper
• DESIGN OF A TARGETED BACTERIAL DRUG DELIVERY VECTOR FOR THE TREATMENT OF CANCER AND METASTASES

  2014cites this paper
• Design and construction of a new biosynthetic pathway for the production of curcuminoids in Escherichia coli

  2012cites this paper